We are live on !
Find out more
Tonix Pharmaceuticals
TNXP
TNXP
hedge funds and large institutions have $48.9M invested in Tonix Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
345% more call options, than puts
Call options by funds: $984K | Put options by funds: $221K
9.53% more ownership
Funds ownership: 39.52% → 49.05% (+9.5%)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $1.69M
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$984K
Puts
$221K
Net Calls
+$763K
Net Calls Change
+$595K
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.15M |
| 2 |
Credit Suisse
Zurich,
Switzerland
|
-$225K |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$164K |
| 4 |
Virtu KCG Holdings
New York
|
-$115K |
| 5 |
Panagora Asset Management
Boston,
Massachusetts
|
-$33K |